Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review

Date: March 28, 2017
Pages: 64
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B71F3E46D61EN
Leaflet:

Download PDF Leaflet

Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Baxter International Inc (Baxter) is one of the leading providers of renal and hospital products. It undertakes the development, manufacture and marketing of medical products, which assist healthcare professionals and their patients in the treatment of end-stage renal diseases. Its portfolio include a comprehensive range of home, acute and in-center dialysis solutions, sterile IV solutions, infusion systems, parenteral nutrition, biosurgery products and anesthetics, and pharmacy automation, software and services. The products find application in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers and clinics. The company distributes its products through its own direct sales force; independent distributors, drug wholesalers acting as sales agents and specialty pharmacies or other alternate site providers. It has wide spread operations in the Americas, Middle East, Africa, Europe and Asia Pacific. Baxter is headquartered in Deerfield, Illinois, the US.

Baxter International Inc Key Recent Developments

Feb 08,2017: Baxter Appoints Dr. Stephen Oesterle to Its Board
Feb 01,2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results
Jan 19,2017: Baxter’s Renal Therapy Services Significantly Reduced Peritonitis Infections among Home Dialysis Patients
Nov 22,2016: Baxter Presented Exploratory Research on the Removal of Inflammation-Related Molecules During Extracorporeal Blood Purification Therapy
Nov 21,2016: New Data Presented at ASN Kidney Week Spotlight Baxter's SHARESOURCE Telehealth Platform and AMIA APD System in Supporting More Efficient Home Dialysis Care

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Baxter International Inc - Key Facts
Baxter International Inc - Key Employees
Baxter International Inc - Key Employee Biographies
Baxter International Inc - Major Products and Services
Baxter International Inc - Medical Equipment Pipeline Products Data
Baxter International Inc Pipeline Products by Equipment Type
Baxter International Inc Pipeline Products by Development Stage
Baxter International Inc - History
Baxter International Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Affiliate
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Baxter International Inc - Business Description
Business Description - Hospital Products
Hospital Products - Overview
Hospital Products - Financials
Business Description - Renal
Renal - Overview
Renal - Financials
Baxter International Inc - Corporate Strategy
Baxter International Inc - SWOT Analysis
SWOT Analysis - Overview
Baxter International Inc - Strengths
Baxter International Inc - Weaknesses
Baxter International Inc - Opportunities
Baxter International Inc - Threats
Baxter International Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Baxter International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Baxter International Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017
Baxter International Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Feb 08, 2017: Baxter Appoints Dr. Stephen Oesterle to Its Board
Feb 01, 2017: Baxter Reports 2016 Fourth-Quarter and Full-Year Results
Nov 22, 2016: Baxter Presented Exploratory Research on the Removal of Inflammation-Related Molecules During Extracorporeal Blood Purification Therapy
Nov 21, 2016: New Data Presented at ASN Kidney Week Spotlight Baxter's SHARESOURCE Telehealth Platform and AMIA APD System in Supporting More Efficient Home Dialysis Care
Nov 17, 2016: Baxter to Present 24 Abstracts at ASN Kidney Week 2016 Focused on Elevating the Standard of Care For Dialysis Patients Globally
Oct 25, 2016: Baxter Reports Third Quarter 2016 Results and Increases Financial Outlook For Full-Year 2016
Sep 08, 2016: Baxter Recognized for 17th Consecutive Year by Dow Jones Sustainability Index (DJSI) as Responsible and Sustainable Business
Jul 27, 2016: Baxter Presents New Evidence Demonstrating REVACLEAR Dialyzer Associated with Lower Drug Use During Hemodialysis
Jul 26, 2016: Baxter Reports Second Quarter 2016 Results and Raises Financial Outlook for Full-Year 2016
May 09, 2016: Baxter Highlights Business Strategies and Innovation at 2016 Investor Conference

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Baxter International Inc, Key Facts
Baxter International Inc, Key Employees
Baxter International Inc, Key Employee Biographies
Baxter International Inc, Major Products and Services
Baxter International Inc Pipeline Products by Equipment Type
Baxter International Inc Number of Pipeline Products by Development Stage
Baxter International Inc Pipeline Products Summary by Development Stage
Baxter International Inc, History
Baxter International Inc, Other Locations
Baxter International Inc, Subsidiaries
Baxter International Inc, Affiliate
Baxter International Inc, Joint Venture
Baxter International Inc, Key Competitors
Baxter International Inc, Ratios based on current share price
Baxter International Inc
Baxter International Inc (Cont.1)
Baxter International Inc, Interim Ratios
Baxter International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Baxter International Inc, Medical Equipment, Deals By Type, 2011 to YTD 2017
Baxter International Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Baxter International Inc Pipeline Products by Equipment Type
Baxter International Inc Pipeline Products by Development Stage
Baxter International Inc, Performance Chart (2012 - 2016)
Baxter International Inc, Ratio Charts
Baxter International Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017
Baxter International Inc, Medical Equipment, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

NxStage Medical Inc
Johnson & Johnson
Hospira Inc
Fresenius Medical Care AG & Co KGaA
Bristol-Myers Squibb Company
Boston Scientific Corp
Becton Dickinson and Co
Abbott Laboratories
Skip to top


Ask Your Question

Baxter International Inc (BAX) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: